NOTE - Biocorp - Strong Buy - Initiation of coverage - TP: €43.8
Biocorp is a French company which has been listed on Euronext Growth since 2015. Its history as a plastics specialist in the pharmaceutical industry served as a springboard to the medtech industry, the ambition of which is to provide patients with connected, miniaturised and customised solutions. Its flagship product Mallya, currently only used in diabetes, incorporates technology suitable for many indications.Biocorp Production SA is a France-based company, which is specialised in the development and manufacturing of medical and drug delivery devices.
Portzamparc is a subsidary of BNP Paribas which adapted the mission to contribute to responsible and sustainable growth of private clients, management companies and SMEs . They offer personalized support adapted to the objectives in particular for Small and Medium-Sized Enterprises.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.